Oncotype DX: Where Does It Stand in India?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncotype DX: Where Does It Stand in India?

Published:2019-12 Issue:5 Volume: Page:1-2
ISSN:2378-9506
Container-title:Journal of Global Oncology
language:en
Short-container-title:JGO

Author:

Batra Atul¹,Patel Amol²,Gupta Vineet Govinda³,Mehta Prashant⁴,TVSVGK Tilak⁵,Biswas Bivas⁶,Pramanik Raja¹,Das Chandan Krishnan⁷,Srivastava Priyanka⁸

Affiliation:

1. All India Institute of Medical Sciences, New Delhi, India

2. Army Hospital-Research and Referral, New Delhi, India

3. Artemis Hospital, Gurugram, India

4. Asian Institute of Medical Sciences, Faridabad, India

5. Armed Forces Medical College, Pune, India

6. Tata Medical Centre, Kolkata, India

7. Post Graduate Institute of Medical Education and Research, Chandigarh, India

8. HM Patel Cancer Centre, Karamsad, India

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology,Cancer Research

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JGO.19.00151

Reference12 articles.

1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

2. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

3. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

4. Profile of breast cancer patients at a tertiary care hospital in north India

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Between Oncotype Dx Recurrence Score and PREDICT Estimates in Early Breast Cancer: A Single Institution Experience;JCO Global Oncology;2024-08

2. Access and barriers to genomic classifiers for breast cancer and prostate cancer in India;International Journal of Cancer;2023-11-14

3. Nomogram Update to Predict the High Genomic Risk Breast Cancer by Different Races;Clinical Breast Cancer;2023-10

4. Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer;JCO Global Oncology;2023-09

5. Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience;Clinical Breast Cancer;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3